Tomorrow, Intellia CSO, @LauraSepplore will lead @OTSociety’s webinar at 10 a.m. ET speaking about the promise of #genomeediting and Intellia’s modular platform for therapeutic use. Click here to register (it’s free!): https://t.co/iQjTSOjzoT #CRISPR https://t.co/CmoOliA35O